TIM-3 Alzheimer’s therapy is emerging as a groundbreaking approach in the battle against Alzheimer’s disease, leveraging principles traditionally employed in immune system cancer therapy.Researchers have discovered that by inhibiting TIM-3, a checkpoint molecule, they can empower microglia—immune cells in the brain—to combat harmful plaques associated with Alzheimer’s.
